Early efficacy and safety of Bedaquiline and Delamanid given together in a "Salvage Regimen" for treatment of drug-resistant tuberculosis.

Indian Journal of Tuberculosis(2019)

引用 24|浏览16
暂无评分
摘要
•There are limited options for Drug -Resistant Tuberculosis(DR-TB) patients who fail on treatment.•DR-TB patients treated with regimens containing both Bedaquiline and Delamanid were assessed for efficacy and adverse events.•Early results show the combination of both drugs is efficacious and safe.
更多
查看译文
关键词
Drug-resistant tuberculosis,Bedaquline,Delaminid,QTc interval,Salvage regimen
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要